UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV

AIDS (London), 2016-01, Vol.30 (1), p.65-73

2016

Volltextzugriff (PDF)

Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers

PloS one, 2013-02, Vol.8 (2), p.e56527

2013

Volltextzugriff (PDF)

Macrophage maturation from blood monocytes is altered in people with HIV, and is linked to serum lipid profiles and activation indices: A model for studying atherogenic mechanisms

PLoS pathogens, 2020-10, Vol.16 (10), p.e1008869-e1008869

2020

Volltextzugriff (PDF)

Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals

PLoS pathogens, 2014-06, Vol.10 (6), p.e1004198

2014

Volltextzugriff (PDF)

Increase in gut permeability and oxidized ldl is associated with post-acute sequelae of SARS-CoV-2

Frontiers in immunology, 2023-05, Vol.14, p.1182544-1182544

2023

Volltextzugriff (PDF)

Altered Lipidome Composition Is Related to Markers of Monocyte and Immune Activation in Antiretroviral Therapy Treated Human Immunodeficiency Virus (HIV) Infection and in Uninfected Persons

Frontiers in immunology, 2019-04, Vol.10, p.785-785

2019

Volltextzugriff (PDF)

Estrogen May Enhance Toll-Like Receptor 4-Induced Inflammatory Pathways in People With HIV: Implications for Transgender Women on Hormone Therapy

Frontiers in immunology, 2022-06, Vol.13, p.879600

2022

Volltextzugriff (PDF)

Cellular fatty acid synthase is required for late stages of HIV-1 replication

Retrovirology, 2017-09, Vol.14 (1), p.45-45, Article 45

2017

Volltextzugriff (PDF)

Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy

PloS one, 2015-10, Vol.10 (10), p.e0139474-e0139474

2015

Volltextzugriff (PDF)

Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine

PloS one, 2013-12, Vol.8 (12), p.e83514-e83514

2013

Volltextzugriff (PDF)

Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop

Pathogens & immunity, 2020, Vol.5 (1), p.143-174

2020

Volltextzugriff (PDF)

Inflammation, Immune Activation, and Antiretroviral Therapy in HIV

Current HIV/AIDS reports, 2017-06, Vol.14 (3), p.93-100

2017

Volltextzugriff (PDF)

Identification of Immune Activation Profiles That May Predict Morbidity During Antiretroviral Therapy Treated HIV Infection

EBioMedicine, 2016-06, Vol.8 (C), p.16-17

Funderburg, Nicholas T.

2016

Volltextzugriff (PDF)

Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients

Current opinion in HIV & AIDS, 2014-01, Vol.9 (1), p.80-86

Funderburg, Nicholas T

2014

Volltextzugriff (PDF)

Diminished responsiveness to human β-defensin-3 and decreased TLR1 expression on monocytes and mDCs from HIV-1-infected patients

Journal of leukocyte biology, 2012-11, Vol.92 (5), p.1103-1109

2012

Volltextzugriff (PDF)

Lipid Abnormalities and Inflammation in HIV Inflection

Current HIV/AIDS reports, 2016-08, Vol.13 (4), p.218-225

2016

Volltextzugriff (PDF)

Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1–infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275)

Journal of clinical lipidology, 2017-01, Vol.11 (1), p.61-69

2017

Volltextzugriff (PDF)

Membrane damage and repair in primary monocytes exposed to human β-defensin-3

Journal of leukocyte biology, 2012-11, Vol.92 (5), p.1083-1091

2012

Volltextzugriff (PDF)

Residual Immune Dysregulation Syndrome in Treated HIV infection

Advances in Immunology, 2013, Vol.119, p.51-83

2013

Volltextzugriff (PDF)

Lipidome Abnormalities and Cardiovascular Disease Risk in HIV Infection

Current HIV/AIDS reports, 2019-06, Vol.16 (3), p.214-223

2019

Volltextzugriff (PDF)

Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2015-04, Vol.68 (4), p.396-404

2015

Volltextzugriff (PDF)

Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy

The Journal of infectious diseases, 2014-04, Vol.209 (8), p.1156-1164

2014

Volltextzugriff (PDF)

Sexual minorities are at elevated risk of cardiovascular disease from a younger age than heterosexuals

Journal of behavioral medicine, 2022-08, Vol.45 (4), p.571-579

2022

Volltextzugriff (PDF)

Rosuvastatin Treatment Reduces Markers of Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy

Clinical infectious diseases, 2014-02, Vol.58 (4), p.588-595

2014

Volltextzugriff (PDF)

Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells

The Journal of infectious diseases, 2011-10, Vol.204 (8), p.1217-1226

2011

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Englisch
(161)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV

Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers

Macrophage maturation from blood monocytes is altered in people with HIV, and is linked to serum lipid profiles and activation indices: A model for studying atherogenic mechanisms

Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals

Increase in gut permeability and oxidized ldl is associated with post-acute sequelae of SARS-CoV-2

Altered Lipidome Composition Is Related to Markers of Monocyte and Immune Activation in Antiretroviral Therapy Treated Human Immunodeficiency Virus (HIV) Infection and in Uninfected Persons

Estrogen May Enhance Toll-Like Receptor 4-Induced Inflammatory Pathways in People With HIV: Implications for Transgender Women on Hormone Therapy

Cellular fatty acid synthase is required for late stages of HIV-1 replication

Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy

Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine

Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop

Inflammation, Immune Activation, and Antiretroviral Therapy in HIV

Identification of Immune Activation Profiles That May Predict Morbidity During Antiretroviral Therapy Treated HIV Infection

Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients

Diminished responsiveness to human β-defensin-3 and decreased TLR1 expression on monocytes and mDCs from HIV-1-infected patients

Lipid Abnormalities and Inflammation in HIV Inflection

Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1–infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275)

Membrane damage and repair in primary monocytes exposed to human β-defensin-3

Residual Immune Dysregulation Syndrome in Treated HIV infection

Lipidome Abnormalities and Cardiovascular Disease Risk in HIV Infection

Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy

Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy

Sexual minorities are at elevated risk of cardiovascular disease from a younger age than heterosexuals

Rosuvastatin Treatment Reduces Markers of Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy

Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells

Aktive Filter

Suchergebnisse filtern